MR Fingerprinting for Vestibular Schwannomas

Launched by MEDICAL UNIVERSITY OF VIENNA · Apr 15, 2021

Keywords

ClinConnect Summary

This clinical trial is studying a new imaging technique called MR Fingerprinting (MRF) to understand how vestibular schwannomas (a type of tumor that affects the nerves in the ear) respond to a specific treatment known as Gamma Knife radiosurgery. The trial will include 50 patients who have a vestibular schwannoma that is at least 1 centimeter in size. Researchers hope to discover patterns in the MR Fingerprinting data that can help predict how well the tumor will respond to the treatment—whether it will be controlled, continue to grow, or change in nature after the procedure.

To be eligible for this study, participants need to be scheduled for Gamma Knife radiosurgery and have a vestibular schwannoma of a minimum size of 1 centimeter. Unfortunately, those with smaller tumors or those who have received other treatments before the study cannot participate. If you join the trial, you'll undergo MR Fingerprinting before your treatment and then have regular follow-up MRIs to see how your tumor responds over time. This research could help improve future treatments for patients with vestibular schwannomas.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria: Planned Gamma Knife radiosurgery for vestibular schwannoma of minimum 1cm in size -
• • Exclusion Criteria: Vestibular Schwannoma of less than 1cm in size. Other a priori treatment than Gamma Knife radiosurgery
• • -